Medindia LOGIN REGISTER
Medindia
Advertisement

Allergy Drops Seem More Efficient Than Shots in Allergy Treatment

by Raja Nandhini on March 28, 2013 at 4:13 AM
Allergy Drops Seem More Efficient Than Shots in Allergy Treatment

A study has found that under-the-tongue drops are more efficient treatment options than shots in treating allergies.

Patients allergic to pollen or grass are required to take weekly injections for many years. Doses containing the allergen are given to strengthen the immunity of the patients to those allergens.

Advertisement

Dr. Sandra Lin at Johns Hopkins University analyzed 63 previous studies, which evaluated the efficacy of sublingual drops in treating allergies. Allergy drops are widely used in Europe and as an off-label drug in USA. FDA has not yet approved the drops therapy in US.

Based on the review it was found that the drops reduced the allergy symptoms by more than 40% when compared with other treatment options like injections.

The author opines that this is an attractive option for many especially kids who are reluctant to take shots.

The report is published online Wednesday in the Journal of the American Medical Association.

Source: Medindia
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

South Korea's 2050 Forecast: Negative Growth Amid Low Fertility
South Korea's total fertility rate, averaging the number of children a woman aged 15-49 has in her lifetime, dropped to 0.81.
New Immunotherapy for Psoriasis & Vitiligo
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
2050 Forecast: 1.06 Billion Individuals to Face 'Other' Musculoskeletal Disorders
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Gene Therapies Can Disrupt Gaucher Disease Drug Market
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
NASH Cases Expected to Hit 26.55 Million in 7MM by 2032
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Allergy Drops Seem More Efficient Than Shots in Allergy Treatment Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests